Top

Published in:

01-04-2015 | Neurology and Preclinical Neurological Studies - Review Article

Editorial: Siegfried Hoyer’s concept of Alzheimer pathophysiology

Authors: Lutz Frölich, Walter E. Müller, Peter Riederer

Published in: Journal of Neural Transmission | Issue 4/2015

Abstract

The concept of central insulin resistance and dysfunctional insulin signaling in Alzheimer's Disease (AD) has been developed by Siegfried Hoyer in 1985–2000. It is widely recognized that the mechanisms underlying neuronal energy deficiency and in particular to elucidate insulin/insulin receptor cascade deficiencies are some of the most relevant proximate characteristics of sporadic AD. The imbalance between cerebral oxygen utilization and cerebral glucose utilization may cause rise in reactive oxygen species production and this might be causal for synapse degeneration. This concept has been substantiated by work on postmortem Alzheimer brains and has been translated back into the streptozotozin animal model, which has stimulated much further research by other researchers. Finally, the insulin hypothesis of Alzheimer's disease has currently advanced into a potential therapeutic avenue.

Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A et al (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69(1):29–38CrossRefPubMedCentralPubMed

Frölich L, Strauss M, Kornhuber J, Hoyer S, Sorbi S, Riederer P, Amaducci L (1990) Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]-QNB binding in rat brain subsequent to intracerebroventricular injection of bromopyruvate. J Neural Transm [PD Sect] 2:169–178CrossRef

Frölich L, Ding A, Hoyer S (1995) Holeboard maze learning deficits in rats and biogenic amines in brain cortex after intracerebroventricular injection of 3-bromopyruvate. Pharmacol Biochem Behavior 51:917–922CrossRef

Frölich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Türk A, Hoyer S, Zöchling R, Boissl KW, Jellinger K, Riederer P (1998) Braininsulin and insulin receptors in aging and sporadic Alzheimer’s disease. J Neural Transm 105(4–5):423–438CrossRefPubMed

Frölich L, Blum-Degen D, Riederer P, Hoyer S (1999) A disturbance of the neuronal insulin receptor signal transduction in sporadic Alzheimer’s disease. Ann NY Acad Sci 893:290–294CrossRefPubMed

Gottstein U, Bernsmeier A, Sedlmeyer I (1963) the carbohydrate metabolism of the human brain. I. Studies with substrate-specific enzymatic methods in normal brain circulation. KlinWochenschr 41:943–948CrossRef

Hoyer S (1986) Senile dementia and Alzheimer’s disease. Brain blood flow and metabolism. Prog Neuropsychopharmacol Biol Psychiatry 10(3–5):447–478CrossRefPubMed

Hoyer S (1991) Abnormalities of glucose metabolism in Alzheimer’s disease. Ann NY Acad Sci 640:53–58PubMed

Hoyer S, Becker K (1966) Cerebral blood flow and brain metabolism findings in neuropsychiatric patients. Nervenarzt 37(7):322–324PubMed

Hoyer S, Nitsch R (1989) Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J Neural Transm 75(3):227–232CrossRefPubMed

Hoyer S, Oesterreich K, Weinhardt F, Krüger G (1975) Blood flow and oxidative metabolism of the brain in patients with dementia (author’s transl). J Neurol 210(4):227–237CrossRefPubMed

Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325(6106):733–736CrossRefPubMed

Kety SS, Schmidt CF (1946) Measurement of cerebral blood flow and cerebral oxygen consumption in man. Fed Proc 5:264PubMed

Masters CL, Beyreuther K (2006) Alzheimer’s centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain 129(Pt 11):2823–2839CrossRefPubMed

Nitsch R, Hoyer S (1991) Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 128(2):199–202CrossRefPubMed

Plaschke K, Hoyer S (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 11(4):477–483CrossRefPubMed

Reger MA, Craft S (2006) Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin. Drugs Today (Barc) 42(11):729–739CrossRef

Riederer P (2014) Univ.-Prof. Dr. med. Siegfried Hoyer 1933–2014. J Neural Transm 121(6):565–567CrossRefPubMed

Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P (2013) What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease about the therapeutic strategies in Alzheimer’s research. J Neural Transm 120(1):233–252CrossRefPubMed

Wadman M (2012) US Government sets out Alzheimer’s plan. Nature 485(7399):426–427CrossRefPubMed

Wickelgren I (1998) Tracking insulin to the mind. Science 280(5363):517–519CrossRefPubMed

Title: Editorial: Siegfried Hoyer’s concept of Alzheimer pathophysiology
Authors: Lutz Frölich
Walter E. Müller
Peter Riederer
Publication date: 01-04-2015
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 4/2015
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-015-1371-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Editorial: Siegfried Hoyer’s concept of Alzheimer pathophysiology

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2015

Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer’s disease pathology

Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice

1H- and 13C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer’s disease

The metabolism hypothesis of Alzheimer’s disease: from the concept of central insulin resistance and associated consequences to insulin therapy

Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer’s disease

Brain catalase in the streptozotocin-rat model of sporadic Alzheimer’s disease treated with the iron chelator–monoamine oxidase inhibitor, M30